Language: English, Spanish, Hebrew, Yiddish
Gender: Male
WCM Physician (What is this?)
Myeloma Center
425 East 61st Street , 8th Floor
New York, NY 10065
Fax
(212) 746-8961
Call
(646) 962-6500

Personal Statement

As the Director of the Multiple Myeloma Center at New York Presbyterian Hospital-Cornell Medical Center, my duties will focus on providing outstanding clinical care and coordinating a world class clinical translational research program. Prestigious investigators have joined forces to create one of the leading centers for myeloma research. I have no doubt that this cooperative effort forms one of the best myeloma research groups on the World.

My 25 years of experience as a myeloma physician has helped me to appreciate how important it is to treat patients in the context of a comprehensive and individualized program. New York Presbyterian Hospital has an outstanding Bone Marrow Transplant Service (a treatment modality often used for myeloma patients), performing more than 100 transplants per year. It has also been rated the best in the world in the fields of cardiology (heart), neurosurgery and nephrology (kidney). The Hospital for Special Surgery, also part of the New York Presbyterian-Weill Cornell system, has an outstanding group of orthopedic surgeons that support a new comprehensive bone disease program. In addition, as part of our continuing search for more effective therapeutic options, we offer multiple clinical trials utilizing promising new drugs and medical procedures for treating myeloma and related hematological disorders.

The ultimate goal is to find the cure for multiple myeloma. The establishment of a free standing Multiple Myeloma Center at New York Presbyterian Hospital Weill Cornell Medical Center is an important step towards the accomplishment of this goal.

For more information, please click here: http://www.Myelomacenter.org

Specialties & Expertise

Specialties

  • Medical Oncology

Expertise

  • Amyloidosis
  • Castleman's Disease
  • Lymphoma
  • Macroglobulinemia
  • Monoclonal Gammopathy of Undetermined Significance
  • Myeloma
  • Multiple Myeloma
  • Plasma Cell Dyscrasia
  • Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • POEMS Syndrome
  • Smoldering Myeloma
  • Waldenstrom's Disease
  • Waldenstrom's Macroglobulinemia

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.

* indicates this physician is no longer accepting new patients with this insurance plan.

  • AETNA - PPO
  • AETNA - Medicare
  • AETNA - HMO
  • Aetna - Weill Cornell - POS
  • Affinity Access
  • Affinity Health Plan
  • Amida Care
  • Blue Priority Network
  • CIGNA
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield - PPO
  • Empire Blue Cross/Blue Shield - Pathway X
  • Empire Blue Cross/Blue Shield - Pathway X Enhanced
  • Empire Blue Cross/Blue Shield - NYPH Employees Only
  • Empire Blue Cross/Blue Shield - Mediblue (Senior)
  • Empire Blue Cross/Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - EPO
  • Empire Empire Blue Cross/Blue Shield HealthPlus
  • Empire Empire Blue Cross/Blue Shield HealthPlus - CHP
  • Fidelis Care
  • GHI - CBP
  • Health First
  • Health Insurance Plan of NY (HIP) - Medicaid
  • Health Insurance Plan of NY (HIP) - Medicare
  • Health Insurance Plan of NY (HIP)
  • Medicaid
  • Medicare
  • Oxford Health Plans - Medicare Advantage
  • Oxford Health Plans - Metro/Core/Charter
  • Oxford Health Plans - Freedom
  • Oxford Health Plans - Liberty
  • POMCO
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care
  • United Health Care - Medicare
  • United Health Care - Community Plan
  • VNSNY CHOICE - Medicare
  • VNSNY CHOICE - HMO
  • WellCare Health Plans

Qualifications

Board Certifications

  • Internal Medicine
  • Hematology

Clinical & Academic Positions

Attending Physician
NewYork-Presbyterian Hospital

Professor of Medicine
Weill Cornell Medical College, Cornell University

Education & Training

  • M.D., National Autonomous University of Mexico, Faculty of Medicine (Mexico), 1985

Honors & Awards

2001-2005: The Leukemia and Lymphoma Society SCOR grant. Clinical Core. 

Translational Research Grant: Awarded by CTEP:NCI. RFP S03-058 SAIC-Frederick

K23 Award: 1 K23 CA109260-01.EXPLOITING NOVEL THERAPEUTIC TARGETS IN MULTIPLE MYELOMA

2007 Investigator Award of the Michael Wolk Heart Foundation

2014: New York Magazine: Top Doctors

2015: Top Doctors for Cancer, Newsweek Magazine

2016, 2017: America's Top Doctors, Castle Connolly

2016, 2017: America's Top Doctors for Cancer, Castle Connolly

2016, 2017: Top Doctors New York Metro Area, Castle Connolly

America's Top Doctors: 14th Edition 

America's Top Doctors for Cancer: 10th Edition 

Top Doctors: New York Metro Area: 18th Edition

Biography

Dr. Niesvizky is Professor of Medicine at Weill Cornell Medical College and at NewYork Presbyterian Hospital/Weill Cornell Medical Center in Manhattan. He also serves as Director of the Multiple Myeloma  Center at NewYork Presbyterian Hospital/Weill Cornell Medical Center. After receiving a medical degree from National University of Mexico, Dr. Niesvizky did a research fellowship in cell biology-granulocytopoiesis and an internal medicine residency at the National Institute of Nutrition in Mexico. He then completed fellowships in New York: one (hematology) at Mount Sinai Medical Center and one (hematology/medical oncology) at Memorial Sloan-Kettering Cancer Center. He has written more than 100 articles, editorials, chapters, and abstracts published in journals such as New England Journal of Medicine, Blood and Leukemia & Lymphoma, most recently on topics such as the treatment of myeloma and Waldenstrom's macroglobulinemia. He is the recipient of various grants and awards from the National Cancer Institute and the Leukemia and Lymphoma Society, including a K23 award and three translational research grants. He received the 2007 Investigator Award of the Michael Wolk Heart Foundation. He has been voted by pears as “Best Doctors” in 2013 and appeared in New York Magazine as Hematolgy “Top Doctors” 2014. A frequent lecturer, Dr Niesvizky regularly presents at annual meetings of the American Society of Hematology and the American Society of Clinical Oncology, of which he is also a member. He is an active member of the International Myeloma Working Group which defines standards of research and practice in myeloma. He is an active participant in clinical trials of promising new drugs and medical procedures for the treatment of myeloma, lymphoma, and related hematologic disorders.